Joel Chopineau

Prof. Joel Chopineau

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1988 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SRSergio Riva
Sergio Riva
JCJoel Chopineau
Joel Chopineau
AKA. P. G. Kieboom
A. P. G. Kieboom
AKAlexander M. Klibanov
Alexander M. Klibanov

18 February 1988 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
JCJoel Chopineau
Joel Chopineau
FMFrank D. McCafferty
Frank D. McCafferty
MTMichel Therisod
Michel Therisod
AKAlexander M. Klibanov
Alexander M. Klibanov

26 January 2016 in Nanoscale
Verified
Journal Article
Closed access
PDF file
EREstelle Rascol
Estelle Rascol
JDJean-Marie Devoisselle
Jean-Marie Devoisselle
JCJoel Chopineau
Joel Chopineau
Over the past two decades, numerous types of nanoparticles (NPs) have been developed for medical applications; however only a few nanomedicines are actually available on the market. One reason is the lack of understanding and data concerning the NP fate and their behavior upon contact with biological media and cell membranes. Biomimetic membrane models are interesting tools to approach and understand NPs–cell membrane interactions. The use of these models permits one to control physical and chemical parameters and to rapidly compare membrane types and the influence of different media conditions. The interactions between NPs and cell membranes can be qualified and quantified using analytical and modeling methods. In this review, the major studies concerning NPs–cell membrane models and associated methods are described. The advantages and drawbacks for each method are compared for the different models. The key mechanisms of interactions between NPs and cell membranes are revealed using cell membrane models and are interrogated in comparison with the NP behavior in cellulo or in vivo. Investigating the interactions between NPs and cell membrane models is now proposed as an intermediate step between physicochemical characterization of NPs and biological assays.

5 July 2007 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
CRClaire Rossi
Claire Rossi
JCJoel Chopineau
Joel Chopineau

31 October 2016 in Nanoscale
Verified
Journal Article
Closed access
PDF file
CPCédric Pisani
Cédric Pisani
JGJean-Charles Gaillard
Jean-Charles Gaillard
MOMichaël Odorico
Michaël Odorico
JNJeff L. Nyalosaso
Jeff L. Nyalosaso
CCClarence Charnay
Clarence Charnay
OPOdette Prat
Odette Prat
Magnetic mesoporous silica nanoparticles (M-MSNs) represent promising targeting tools for theranostics. Engineering the interaction of nanoparticles (NPs) with biological systems requires an understanding of protein corona formation around the nanoparticles as this drives the biological fate of nanocarriers. We investigated the behavior of proteins in contact with M-MSNs by high-throughput comparative proteomics, using human and bovine sera as biological fluids, in order to assess the adsorption dynamics of proteins in these media. Using system biology tools, and especially protein–protein interaction databases, we demonstrated how the protein network builds up within the corona over the course of the experiment. Based on these results, we introduce and discuss the role of the “corona interactome” as an important factor influencing protein corona evolution. The concept of the “corona interactome” is an original methodology which could be generalized to all NP candidates. Based on this, pre-coating nanocarriers with specific proteins presenting minimal interactions with opsonins might provide them with properties such as stealth.

1 December 2003 in Biochemistry
Verified
Journal Article
Closed access
CRClaire Rossi
Claire Rossi
JHJohanne Homand
Johanne Homand
CBCécile Bauche
Cécile Bauche
HHHayfa Hamdi
Hayfa Hamdi
Daniel LadantDaniel Ladant
Daniel Ladant
JCJoel Chopineau
Joel Chopineau